Paul Andersson

1.3k total citations
30 papers, 1.1k citations indexed

About

Paul Andersson is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Paul Andersson has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Paul Andersson's work include Asthma and respiratory diseases (14 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Inhalation and Respiratory Drug Delivery (7 papers). Paul Andersson is often cited by papers focused on Asthma and respiratory diseases (14 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Inhalation and Respiratory Drug Delivery (7 papers). Paul Andersson collaborates with scholars based in Sweden, France and Netherlands. Paul Andersson's co-authors include Åke Ryrfeldt, Staffan Edsbäcker, Derek Davies, Ruben Pauwels, Anders Åström, G. Jönsson, Ulf Pipkorn, Ralph Brattsand, C. G. A. Persson and I. Erjefält and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Allergy.

In The Last Decade

Paul Andersson

29 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Andersson Sweden 17 548 399 211 123 122 30 1.1k
Alan K. Kamada United States 13 523 1.0× 385 1.0× 75 0.4× 84 0.7× 37 0.3× 29 883
Sang‐Hoon Kim South Korea 19 267 0.5× 199 0.5× 51 0.2× 46 0.4× 105 0.9× 59 859
Bo Odlind Sweden 21 138 0.3× 189 0.5× 52 0.2× 98 0.8× 102 0.8× 56 1.4k
S. A. Marsico Italy 23 663 1.2× 764 1.9× 77 0.4× 35 0.3× 108 0.9× 46 1.5k
Shigenobu Umeki Japan 19 192 0.4× 179 0.4× 43 0.2× 41 0.3× 144 1.2× 89 1.1k
C. Hardy United Kingdom 14 493 0.9× 299 0.7× 114 0.5× 27 0.2× 46 0.4× 21 817
Mitsuyoshi Utsugi Japan 22 282 0.5× 379 0.9× 38 0.2× 28 0.2× 118 1.0× 53 1.3k
Shamsah Kazani United States 14 565 1.0× 421 1.1× 77 0.4× 25 0.2× 53 0.4× 30 1.2k
Daniela S. Bundschuh Germany 12 570 1.0× 566 1.4× 56 0.3× 30 0.2× 115 0.9× 15 1.2k
Md Ashik Ullah Australia 15 205 0.4× 189 0.5× 48 0.2× 23 0.2× 138 1.1× 44 863

Countries citing papers authored by Paul Andersson

Since Specialization
Citations

This map shows the geographic impact of Paul Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Andersson more than expected).

Fields of papers citing papers by Paul Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Andersson. The network helps show where Paul Andersson may publish in the future.

Co-authorship network of co-authors of Paul Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Andersson. A scholar is included among the top collaborators of Paul Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Andersson. Paul Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ewing, Pär, et al.. (2009). Vasoconstriction after inhalation of budesonide: A study in the isolated and perfused rat lung. Pulmonary Pharmacology & Therapeutics. 23(1). 9–14. 10 indexed citations
2.
Eirefelt, Stefan, et al.. (2008). Short Inhalation Exposures of the Isolated and Perfused Rat Lung to Respirable Dry Particle Aerosols; the Detailed Pharmacokinetics of Budesonide, Formoterol, and Terbutaline. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 21(2). 169–180. 22 indexed citations
3.
Kvam, Tor, et al.. (2004). Aldersbestemmelse av elg felt i Nærøy kommune 2001 og 2002. BIBSYS Brage (BIBSYS (Norway)). 1 indexed citations
4.
Sharma, Vyas, et al.. (2002). Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST). Drug Metabolism and Disposition. 30(5). 582–585. 45 indexed citations
5.
Andersson, Paul, et al.. (2001). Reacidification Effects on Water Chemistry and Plankton in a Limed Lake in Sweden. Water Air & Soil Pollution. 130(1-4). 1763–1768. 5 indexed citations
6.
Marelius, John, Åsa Helen Persson, Göte Swedberg, et al.. (2000). Computational Predictions of Binding Affinities to Dihydrofolate Reductase:  Synthesis and Biological Evaluation of Methotrexate Analogues. Journal of Medicinal Chemistry. 43(21). 3852–3861. 22 indexed citations
7.
8.
Jönsson, G., Anders Åström, & Paul Andersson. (1995). Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver.. Drug Metabolism and Disposition. 23(1). 137–142. 131 indexed citations
9.
Nielsen, Jörn, Hans Welinder, Inger Bensryd, Paul Andersson, & Staffan Skerfving. (1994). Symptoms and immunologic markers induced by exposure to methyltetrahydrophthalic anhydride. Allergy. 49(4). 281–286. 21 indexed citations
10.
Sovijärvi, Anssi, et al.. (1992). Preventive Effects of Inhaled Formoterol and Salbutamol on Histamine-lnduced Bronchoconstriction – A Placebo-Controlled Study. Respiration. 59(5). 279–282. 4 indexed citations
11.
Andersson, M., C. Svensson, Paul Andersson, & Ulf Pipkorn. (1989). Objective Monitoring of the Allergic Inflammatory Response of the Nasal Mucosa in Patients with Hay Fever during Natural Allergen Exposure. American Review of Respiratory Disease. 139(4). 911–914. 43 indexed citations
12.
Andersson, M., Paul Andersson, Per Venge, & Ulf Pipkorn. (1989). Eosinophils and eosinophil cationic protein in nasal lavages in allergen‐induced hyperresponsiveness: effects of topical glucocorticosteroid treatment. Allergy. 44(5). 342–348. 54 indexed citations
13.
Andersson, Morgan, et al.. (1987). Allergen‐induced nasal hyperreactivity appears unrelated to the size of the nasal and dermal immediate allergic reaction. Allergy. 42(8). 631–637. 36 indexed citations
14.
Chignard, Michel, et al.. (1986). Use of Steroidal Antiinflammatory Drug Provides Further Evidence for a Potential Role of PAF-Acether in Bronchial Anaphylaxis. International Archives of Allergy and Immunology. 81(2). 184–185. 11 indexed citations
15.
Wieslander, Elisabet, et al.. (1985). Importance of particulate antigen for the induction of dual bronchial reaction in guinea-pigs. Inflammation Research. 16(1-2). 37–38. 21 indexed citations
16.
Andersson, Paul, et al.. (1984). Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17α,21-dipropionate in human liver and lung homogenate. Journal of Pharmacy and Pharmacology. 36(11). 763–765. 68 indexed citations
17.
Andersson, Paul, O Olsson, & Bertil Waldeck. (1982). Some Problems Encountered in the Evaluation of New Bronchodilating β‐Adrenoceptor Agonists. Acta Pharmacologica et Toxicologica. 51(4). 358–364. 8 indexed citations
18.
Andersson, Paul, Staffan Edsbäcker, Åke Ryrfeldt, & Christer von Bahr. (1982). In vitro biotransformation of glucocorticoids in liver and skin homogenate fraction from man, rat and hairless mouse. Journal of Steroid Biochemistry. 16(6). 787–795. 34 indexed citations
19.
Ryrfeldt, Åke, et al.. (1982). Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid.. PubMed. 122. 86–95. 271 indexed citations
20.
Andersson, Paul & Håkan Persson. (1977). Effect of Substance P on Pulmonary Resistance and Dynamic Pulmonary Compliance in the Anaesthetized Cat and Guinea‐pig. Acta Pharmacologica et Toxicologica. 41(5). 444–448. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan K. Kamada Breakdown of academic impact, for papers by Sang‐Hoon Kim Breakdown of academic impact, for papers by Bo Odlind Breakdown of academic impact, for papers by S. A. Marsico Breakdown of academic impact, for papers by Shigenobu Umeki Breakdown of academic impact, for papers by C. Hardy Breakdown of academic impact, for papers by Mitsuyoshi Utsugi Breakdown of academic impact, for papers by Shamsah Kazani Breakdown of academic impact, for papers by Daniela S. Bundschuh Breakdown of academic impact, for papers by Md Ashik Ullah
Rankless by CCL
2026